Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1984-05-21
1986-02-11
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
2601125LH, 2601125R, C07C10352, A61K 3702
Patent
active
045699275
ABSTRACT:
Peptides which inhibit the secretion of gonadotropins by the pituitary gland and inhibit the release of steroids by the gonads. Administration of an effective amount prevents ovulation of female mammalian eggs and/or the release of steroids by the gonads. The peptides have the structure:
REFERENCES:
patent: 4317815 (1982-03-01), Coy et al.
patent: 4341767 (1982-07-01), Nestor et al.
patent: 4444759 (1984-04-01), Rivier et al.
Coy et al., Endocrinology, vol. 110, No. 4, 1982, pp. 1445-1447.
Yabe et al., "Synthesis and Biological Activity of LH-RH Analogs Substituted by Alkyltryptophans at Position 3.sup.1)", Chem. Pharm. Bull., 27(8) 1907-1911, (1979).
Rivier Jean E. F.
Vale, Jr. Wylie W.
Moezie F. T.
Phillips Delbert R.
The Salk Institute for Biological Studies
LandOfFree
GnRH Antagonists IV does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with GnRH Antagonists IV, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and GnRH Antagonists IV will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1205675